Back to Results
First PageMeta Content
Clinical research / Design of experiments / Evaluation methods / Pharmacology / Epidemiology / Olmesartan / Angiotensin II receptor antagonist / Cohort / Clinical trial / Science / Research / Statistics


021286_Olmesartan_Statistical_BPCA
Add to Reading List

Open Document

File Size: 527,09 KB

Share Result on Facebook

Company

Sankyo / OM group / BP / ITT / /

Continent

Africa / /

Country

United States / India / /

Event

Product Issues / Product Recall / FDA Phase / /

IndustryTerm

placebo / dose groups / /

MedicalCondition

secondary hypertension / /

Organization

U.S. Department of Health and Human Services / FOOD AND DRUG ADMINISTRATION / Food and Drug Administration Center for Drug Evaluation / Pharmacoepidemiology and Statistical Science Office / Medical Division / Research office of Pharmacoepidemiology / /

Person

Concurring Reviewers / James Hung / Quynh Nguen Keywords / Valeria Freidlin / Shen Xiao / /

Position

Project Manager / M.D. Project Manager / /

Product

olmesartan medoxomil / Benicar / phase of the study / study / placebo group / S-018 / U301 / /

Region

Latin America / /

Technology

alpha / /

SocialTag